Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment

NCT01851018 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: Hypofraction
RADIATION: Standard

Sponsor

CHU de Quebec-Universite Laval

Collaborators

[object Object]